GAS6 and metabolic dysfunction-associated steatotic liver disease: To address the role of Gas6 in NAFLD and in the progression to liver fibrosis, an animal model was studied, e.g., Gas6 KO mice fed with a choline-deficient ethionine-supplemented diet (CDE) or receiving a CCl4 treatment [97].